SCHEMBL7590434

SCHEMBL7590434

CCCCCc1ccc(C(=O)Nc2ccc(S(=O)(=O)N[C@H](Cc3ccccc3)C(=O)O)cc2)cc1

nearest known ligand 0.75

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 11/20 0.75
TRPV1 Q8NER1 1/20 0.57
ALDH1A1 P00352 1/20 0.56
MAPT P10636 1/20 0.56
MMP2 P08253 7/20 0.56
ADAMTS4 O75173 1/20 0.56
ITGB3 P05106 2/20 0.55
ITGA2B P08514 2/20 0.55
ITGB1 P05556 1/20 0.55
ITGAV P06756 1/20 0.55
ITGB5 P18084 1/20 0.55
TDP1 Q9NUW8 1/20 0.53
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
KDM4E B2RXH2 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6424104 0.92 MMP9 (0.62) MMP9TRPV1ALDH1A1MMP2ITGB3
SCHEMBL8193360 0.92 MMP9 (0.62) MMP9TRPV1ALDH1A1MMP2ITGB3
SCHEMBL8070197 0.88 MMP9 (0.58) MMP9TRPV1MMP2ITGB3ITGA2B
SCHEMBL7583683 0.88 MMP9 (0.58) MMP9TRPV1ALDH1A1MAPTITGB3
SCHEMBL7675244 0.86 MMP9 (1.00) MMP9ALDH1A1MAPTMMP2ADAMTS4
SCHEMBL7668862 0.86 MMP9 (1.00) MMP9ALDH1A1MAPTMMP2ADAMTS4
SCHEMBL5093780 0.86 MMP9 (1.00) MMP9ALDH1A1MAPTMMP2ADAMTS4
SCHEMBL7669356 0.86 MMP9 (1.00) MMP9ALDH1A1MAPTMMP2ADAMTS4
SCHEMBL14191415 0.83 MMP9 (0.93) MMP9ALDH1A1MAPTMMP2ADAMTS4
SCHEMBL14191416 0.83 MMP9 (0.84) MMP9ALDH1A1MAPTMMP2ADAMTS4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6177466-B1 Sulfonylamino acid derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 2001-01-23 US claimed
EP-0757037-A2 Sulfonylamino acid derivatives as metalloproteinase inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 1997-02-05 EP claimed
EP-0757984-B1 Hydroxamic acid derivatives useful for inhibiting gelatinase ONO PHARMACEUTICAL CO (JP) 2002-10-30 EP disclosed
US-6403644-B1 FOR PREVENTION AND/OR TREATMENT OF DISEASES INDUCED BY OVEREXPRESSION AND EXCESS ACTIVITY OF MATRIX METALLOPROTEINASE; FOR EXAMPLE, RHEUMATOID, ARTHROSTEITIS, UNUSUAL BONE RESORPTION, OSTEOPOROSIS, PERIODONTITIS ONO PHARMACEUTICAL CO., LTD. (JP) 2002-06-11 US disclosed
US-6177466-B1 Sulfonylamino acid derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 2001-01-23 US disclosed
US-6022893-A PREVENTION AND TREATMENT OF DISEASES INDUCED BY OVEREXPRESSION OR EXCESS ACTIVATION OF GELATINASES ONO PHARMACEUTICAL CO., LTD. (JP) 2000-02-08 US disclosed
EP-0757984-A1 Hydroxamic acid derivatives useful for inhibiting gelatinase ONO PHARMACEUTICAL CO., LTD. (JP) 1997-02-12 EP disclosed
EP-0757037-A2 Sulfonylamino acid derivatives as metalloproteinase inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 1997-02-05 EP disclosed